# OLAPARIB
> **ANDA217936** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2025-05-22
## Drug
- **FDA Application Number:** ANDA217936
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLAPARIB
- **Generic name:** Olaparib
- **Active ingredients:** OLAPARIB
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SANDOZ INC
- **First approval:** 2025-05-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217936)
---
*MORVS · CC0 1.0*